Australia markets closed

NanoVibronix, Inc. (56R0.F)

Frankfurt - Frankfurt Delayed price. Currency in USD
Add to watchlist
0.0000-5.8200 (-100.00%)
As of 09:29AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
2,850
2,283
752
1,695
623
-
Cost of revenue
884
746
585
925
409
-
Gross profit
1,966
1,537
167
770
214
-
Operating expenses
Research development
251
185
283
293
171
-
Selling general and administrative
4,664
4,788
4,896
6,160
4,762
-
Total operating expenses
4,915
4,973
5,179
6,453
4,933
-
Operating income or loss
-2,949
-3,436
-5,012
-5,683
-4,719
-
Interest expense
135
135
347
0
147
-
Total other income/expenses net
-
-
-
-8,519
555
-598
Income before tax
-3,168
-3,682
-5,413
-14,250
-4,311
-
Income tax expense
34
29
35
32
15
-
Income from continuing operations
-3,202
-3,711
-5,448
-14,282
-4,326
-
Net income
-3,202
-3,711
-5,448
-14,282
-4,326
-
Net income available to common shareholders
-3,202
-3,711
-5,448
-14,282
-4,326
-
Basic EPS
-3.15
-
-3.84
-11.35
-8.40
-16.60
Diluted EPS
-3.15
-
-3.84
-11.35
-8.40
-16.60
Basic average shares
1,629
-
1,420
1,258
514.905
346.967
Diluted average shares
1,629
-
1,420
1,258
514.905
346.967